Literature DB >> 9142728

Indium-111 labelled lymphocytes: isotope distribution and cell division.

J Kuyama1, A McCormack, A J George, B T Heelan, S Osman, J R Batchelor, A M Peters.   

Abstract

Since lymphocytes continue to proliferate and divide in vivo, it is important to determine the fate of a radionulide following lymphocyte labelling. Using the mixed lymphocyte reaction (MLR), we induced indium-111 labelled lymphocytes from a specific in-bred rat strain (AS) to divide and then observed the subsequent 111In distribution between cells and supernatant. L10 and L12.4 cells, which are allospecific CD4+ T lymphocytes from the AS rat, were stimulated in the MLR by antigen-presenting cells from the August rat, a different strain. We labelled L10 or L12.4 lymphocytes on day 0, the first day of the stimulation cycle, and continued to culture the lymphocytes in vitro. The proliferation of the cells was estimated according to their increase in number. The distribution of 111In between cell and supernatant fractions and between viable and dead (but intact) cells was measured in the cell suspension each day after labelling. The metabolic activity of 111In-labelled lymphocytes was compared with control cells by measuring their uptake of fluorine-18 fluorodeoxyglucose ([18F]FDG). 111In-labelled lymphocytes showed a poor proliferative response compared with control cells 24-48 h after labelling but increased in number after this time. From 24 to 72 h, about 70% of 111In was in the supernatant but only about 5%-10% was associated with intact dead cells. These dead cells tended to retain their 111In, losing less than 30% per day, suggesting that 111In in the supernatant was the result of active elimination from viable cells. Moreover, 24 h after culture, considerably more 111In was associated with viable than with dead lymphocytes, although over the next few days this distribution reversed. 111In-labelled lymphocytes took up more [18F]FDG than control cells at 24 h but not at 0 or 72-96 h; the maximum [18F]FDG uptake coincided with the greatest reduction in cell number. Furthermore, [18F]FDG uptake correlated with the initial 111In burden in lymphocytes labelled with 111In 24 h previously. The results are consistent with active elimination of 111In by 111In-labelled lymphocytes. The energy requirements for this are diverted away from cell division, thereby increasing the probability of cell death. As lymphocytes become 111In deplete, they recover their capacity to proliferate and their risk of death decreases. These findings have important implications for 111In-labelled lymphocyte scintigraphy, suggesting that cells remaining viable immediately after labelling will either subsequently die or alternatively eliminate the label.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9142728     DOI: 10.1007/bf01267679

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  17 in total

1.  Distribution of cell-free and cell-associated HIV surrogates in the colon after simulated receptive anal intercourse in men who have sex with men.

Authors:  Nicolette A Louissaint; Sridhar Nimmagadda; Edward J Fuchs; Rahul P Bakshi; Ying-Jun Cao; Linda A Lee; Jeff Goldsmith; Brian S Caffo; Yong Du; Karen E King; Frederick A Menendez; Michael S Torbenson; Craig W Hendrix
Journal:  J Acquir Immune Defic Syndr       Date:  2012-01-01       Impact factor: 3.731

2.  The role of molecular imaging in the development of dendritic cell-based cancer vaccines.

Authors:  Giovanni Lucignani; Maria Rescigno
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-07       Impact factor: 9.236

Review 3.  Imaging of cells and nanoparticles: implications for drug delivery to the brain.

Authors:  Katica Stojanov; Inge S Zuhorn; Rudi A J O Dierckx; Erik F J de Vries
Journal:  Pharm Res       Date:  2012-07-18       Impact factor: 4.200

Review 4.  Stem cell therapy for cardiovascular disease: the demise of alchemy and rise of pharmacology.

Authors:  T Jadczyk; A Faulkner; P Madeddu
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

5.  Brain ingress of regulatory T cells in a murine model of HIV-1 encephalitis.

Authors:  Nan Gong; Jianuo Liu; Ashley D Reynolds; Santhi Gorantla; R Lee Mosley; Howard E Gendelman
Journal:  J Neuroimmunol       Date:  2010-09-16       Impact factor: 3.478

6.  Ex vivo cell labeling with 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography.

Authors:  Nona Adonai; Nora Adonai; Khoi N Nguyen; Joseph Walsh; M Iyer; Tatsushi Toyokuni; Michael E Phelps; Timothy McCarthy; Deborah W McCarthy; Sanjiv Sam Gambhir
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

7.  Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction.

Authors:  Dara L Kraitchman; Mitsuaki Tatsumi; Wesley D Gilson; Takayoshi Ishimori; Dorota Kedziorek; Piotr Walczak; W Paul Segars; Hunter H Chen; Danielle Fritzges; Izlem Izbudak; Randell G Young; Michelle Marcelino; Mark F Pittenger; Meiyappan Solaiyappan; Raymond C Boston; Benjamin M W Tsui; Richard L Wahl; Jeff W M Bulte
Journal:  Circulation       Date:  2005-08-29       Impact factor: 29.690

8.  Ferumoxytol Is Not Retained in Kidney Allografts in Patients Undergoing Acute Rejection.

Authors:  Maryam Aghighi; Laura Pisani; Ashok J Theruvath; Anne M Muehe; Jessica Donig; Ramsha Khan; Samantha J Holdsworth; Neeraja Kambham; Waldo Concepcion; Paul C Grimm; Heike E Daldrup-Link
Journal:  Mol Imaging Biol       Date:  2018-02       Impact factor: 3.488

9.  Indium-labelled human gut-derived T cells from healthy subjects with strong in vitro adhesion to MAdCAM-1 show no detectable homing to the gut in vivo.

Authors:  J Kelsen; J Agnholt; L Falborg; J T Nielsen; J L Rømer; H J Hoffmann; J F Dahlerup
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

10.  Bone Marrow Cell Trafficking Analyzed by 89Zr-oxine Positron Emission Tomography in a Murine Transplantation Model.

Authors:  Kingsley O Asiedu; Sho Koyasu; Lawrence P Szajek; Peter L Choyke; Noriko Sato
Journal:  Clin Cancer Res       Date:  2016-12-13       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.